According to a Bloomberg report, US-based private equity investor, Advent International, is looking at a €5bn (US$5.4bn) sale of Zentiva, a Czech-based pharmaceutical company manufacturing and supplying generic and OTC…
Czech Republic: Bloomberg reports Advent mulling options for sale of Zentiva
…
…



